Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 498130
                    [Title] => Amyloid scans may aid Alzheimer's diagnosis
                    [Summary] => 
Radionuclide imaging products that reliably detect cerebral amyloid deposits would be clinically useful in ruling out a diagnosis of Alzheimer’s disease in patients with cognitive impairment, according to a Food and Drug administration advisory panel.
                    [DatePublished] => 2009-08-23 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 62817
                    [Title] => FDA calls for stronger antidepressant warning
                    [Summary] => 
            
                    [DatePublished] => 2008-05-18 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

        )

)

DRUGS ADVISORY COMMITTEE

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 498130
                    [Title] => Amyloid scans may aid Alzheimer's diagnosis
                    [Summary] => 
Radionuclide imaging products that reliably detect cerebral amyloid deposits would be clinically useful in ruling out a diagnosis of Alzheimer’s disease in patients with cognitive impairment, according to a Food and Drug administration advisory panel.
                    [DatePublished] => 2009-08-23 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 62817
                    [Title] => FDA calls for stronger antidepressant warning
                    [Summary] => 
            
                    [DatePublished] => 2008-05-18 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

        )

)

abtest

Amyloid scans may aid Alzheimer's diagnosis

By YOUR DOSE OF MEDICINE | By Charles C. Chante MD | August 23, 2009 - 12:00am

Radionuclide imaging products that reliably detect cerebral amyloid deposits would be clinically useful in ruling out a diagnosis of Alzheimer’s disease in patients with cognitive impairment, according to a...

Opinion

FDA calls for stronger antidepressant warning

By YOUR DOSE OF MEDICINE | By Charles C. Chante MD | May 18, 2008 - 12:00am

Opinion